Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

DiaSorin S.p.A (DIA) - Financial and Strategic SWOT Analysis Review

DiaSorin S.p.A. (DiaSorin) is a medical device company.

It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation.

Its major product offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA).

The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation.

DiaSorin Group operates through 23 companies and five branches in Europe, the US, Central and South America and Asia.

DiaSorin S.p.A Key Recent Developments

Aug 01, 2013: The Board of Directors approves the results for the H1 '13
Jul 24, 2013: DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM
Jul 11, 2013: DiaSorin gets approval tests Hepatitis and Retrovirus of CLIA in Brazil
Jun 28, 2013: DiaSorin launches the test of Chlamydia Trachomastis IgG and IgA on LIAISON
May 10, 2013: Diasorin Reports Q1 2013 Results

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings